Table 2.
Variables | Group | Baseline | Acute 1 | Acute 2 | Adaptation |
---|---|---|---|---|---|
Growth hormone (ng/mL) |
BFR | 0.83 ± 0.12 | 8.56 ± 3.17*# | 2.53 ± 1.32* | 1.10 ± 0.36 |
non-BFR | 0.87 ± 0.05 | 3.92 ± 1.47* | 1.68 ± 0.07* | 0.89 ± 0.06 | |
Testosterone (ng/mL) |
BFR | 5.52 ± 0.67 | 8.55 ± 1.43*# | 7.52 ± 0.96* | 6.63 ± 0.97 |
non-BFR | 4.75 ± 0.73 | 6.08 ± 1.29* | 6.33 ± 0.58* | 5.55 ± 0.99 | |
Cortisol (ng/mL) |
BFR | 108.83 ± 15.77 | 185.82 ± 13.74* | 156.83 ± 42.47* | 112.80 ± 28.73 |
non-BFR | 109.27 ± 25.45 | 194.02 ± 11.07* | 153.48 ± 35.49 | 104.80 ± 12.15 | |
Ratio (%) |
BFR | 0.051 ± 0.006 | 0.046 ± 0.007# | 0.050 ± 0.011 | 0.061 ± 0.011* |
non-BFR | 0.051 ± 0.01 | 0.032 ±0.007* | 0.044 ± 0.014 | 0.053 ± 0.010 |
BFT, blood flow restriction; baseline, before getting pre-testing; Acute1, immediately after first session; Acute 2, immediately after last session; adaptation, 48 h after last training session.
* intragroup significant differences with Baseline at p < 0.05;
# intergroup significant differences at p < 0.05.